ArticleNPJ digital medicine2026
Graphicalized vision-language modeling for comprehensive lung nodule analysis and risk stratification.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Lung cancer care involves coupled tasks such as precise nodule detection, patient-level survival risk estimation, and nodule count quantification, typically handled by separate systems despite clear interdependence. We present VITALIS, a multimodal vision-language framework that fuses CT and PET/CT imaging with structured radiology text using a graph-aware Transformer: Laplacian diffusion enriches token features on an image-text graph, while structural and prior-guided attention focus computation on anatomically and clinically related contexts, followed by bidirectional image-text conditioning to form a fused patient representation. This representation parameterizes a continuous-time latent risk process governed by a context-modulated Neural ODE, enabling individualized continuous-time modeling of time-to-event risk. Task-specific heads decode the latent trajectory into nodule detection, nodule malignancy classification, survival risk estimation, and nodule count prediction. Evaluated on three public cohorts, the framework delivers accurate delineations, low-false-positive localization, calibrated survival risk estimates, and consistent nodule counts across tasks. These findings indicate that coupling graph-aware multimodal encoding with continuous-time latent dynamics provides a coherent basis for integrated diagnostic and prognostic modeling in lung cancer.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.